uBiome Expands Product Portfolio, Drug Discovery & Development

uBiome Announces $83 Million Series C Financing

uBiome Will Expand World’s Largest Human Microbiome Database 
and Advance Product Portfolio, 
Including Drug Discovery & Development
September 21, 2018

Considered to be "the leader in microbial genomics", uBiome announces that it has received $83 Million Series C Financing to expand its world's largest human microbiome database, advance product portfolio, drug discovery & development.

Proceeds of the financing will be used to:

• Enhance and expand the Company’s product portfolio
• Leverage insights gained by building largest microbiome database to expand into drug research and development using pre-existing patent assets and industry research collaborations, not data sales
• Accelerate and expand commercialization of SmartGut, SmartJane, Explorer and other clinical tests under development, including companion diagnostics
• Begin commercialization of biopharma molecules and live biotherapeutics based on mining of existing IP

uBiome has partnered with more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, University of California, San Francisco, the Massachusetts Institute of Technology, Oxford University, and the University of Sydney.

-SAN FRANCISCO-Business Wire-

MEBO is currently participating in the uBiome's database expansion. It is our hope, though not a guarantee...that this clinical trial will ultimately lead to drug discovery & development.

With a uBiome Research Grant sponsoring MEBO's Clinical Trial, NCT02683876, "Microbial Basis of Systemic Malodor and PATM Conditions", MEBO is currently participating in the uBiome's database expansion. It is our hope, though not a guarantee, as stated in MEBO's Research Consent Form, that this clinical trial will ultimately lead to drug discovery & development.

The international MEBO community is most grateful to uBiome for the research grant it has awarded us for our Clinical Trial. We look forward to uBiome's expansion of its advanced product portfolio and drug discovery and development, which we hope will help our community arrive at proper diagnoses and targeted, personalized treatment protocols moving forward.

María

María de la Torre
Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.com
www.meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)

---

SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.

get New Posts by EMAIL : Enter your email address :

---

A EURORDIS and NORD Member Organization